POSTER SESSION III Tuesday, February 14, 2006   —  9:30 AM - 12:00 Noon Exhibit Level GENITOURINARY PATHOLOGY 77 Separation of Chromophobe Renal Cell Carcinoma from Oncocytoma and Clear Cell Carcinoma:An Optimal Immunohistochemical Panel for Differential Diagnosis (575) L Liu, J Qian, H Singh, I Meiers, TL Tops, X Zhou, DG Bostwick - Bostwick Laboratories, Glen Allen, VA 78 Expression of Human Kidney Injury Molecule-1 (hKIM-1) in Renal Cell Neoplasms (677) F Lin, PL Zhang, XJ Yang, JV Bonventre - Geisinger Medical Center, Danville, PA; Northwestern Memorial Hospital, Chicago, IL; Brigham and Women's Hospital, Boston, MA 79 Expression of S-100 Protein in Renal Cell Neoplasms (678) F Lin, WN Yang, XJ Yang - Geisinger Medical Center, Danville, PA; Northwestern Memorial Hospital, Chicago, IL 80 Ceruloplasmin Immunoreactivity in Renal Cell Carcinoma (735) KT Schafernak, BP Adley, V Papavero, BT Teh, XJ Yang - Northwestern University Feinberg School of Medicine, Chicago, IL; Van Andel Research Institute, Grand Rapids, MI 81 Angiomyolipoma with Epithelial Cysts (AMLEC): A Distinct Cystic Variant of Angiomyolipoma (586) P Argani, JI Epstein, VE Reuter, SW Fine - Johns Hopkins University, Baltimore, MD; Memorial Sloan Kettering Cancer Center, New York, NY 82 Expanding the Morphologic Spectrum of Mucinous, Tubular, and Spindle Cell Carcinomas: Emphasis on "Mucin-Poor" Variants (625) SW Fine, P Argani, AM De Marzo, B Delahunt, TJ Sebo, VE Reuter, JI Epstein - Johns Hopkins Hospital, Baltimore, MD 83 Loss of Heterozygosity of TSC2 and TSC1 Gene in Perivascular Epithelioid Cell Tumor (PEComa) (708) CC Pan, MY Chung - Taipei Veterans General Hospital, National Yang Ming University, Taipei, Taiwan, Taiwan 84 Expression of S-100A4 Protein in Renal Cell Carcinoma Associated with High Tumor Grade and Metastasis (679) F Lin, C Wood, XJ Yang, WN Yang - Geisinger Medical Center, Danville, PA; Northwestern Memorial Hospital, Chicago, IL 85 High Carbonic Anhydrase (CA) IX Protein Tissue Expression Predicts Response to Interleukin (IL)-2 Based Therapy for Advanced Renal Cell Carcinoma Patients (739) RB Shah, A Amin, R Mehra, T Braun, B Redman - University of Michigan, Ann Arbor, MI 86 Loss Expression Of VHL Protein In Metastatic Renal Cell Carcinoma Associated With Overexpression Of p53 (680) H Liu, K Zhang, T Blasick, PL Zhang, M Ahmed, F Lin - Geisinger Medical Center, Danville, PA 87 Defective DNA Repair Gene, hOGG1, in Clear Cell Renal Cell Carcinoma (634) N Gokden, H Zhang, L Ai, B Smoller, C-Y Fan - University of Arkansas for Medical Sciences, Little Rock, AR 88 Loss of Heterozygosity of DNA Repair Gene, hOGG1, in Clear Cell Renal Cell Carcinoma but not in Renal Cortical Adenoma (635) N Gokden, L Li, H Zhang, RF Schafer, S Schichman, MA Scott, BR Smoller, C Fan - University of Arkansas for Medical Sciences, Little Rock, AR 89 c-kit Protein Immunoreactivity In Renal Cell Carcinoma With Sarcomatoid Dediffrentiation (600) S Bishu, V Papavero, BP Adley, F Lin, XJ Yang - Northwestern University, Chicago, IL 90 Prognostic Utility of Ki-67, EGFR, Cyclin D1, IGF-I, IGFBP-3 and L1-CAM in Clear Cell Renal Cell Carcinoma (CRCC) (768) O Tulunay, M Che, B Pruetz, M Cher, W Sakr, D Grignon - Medical School of Ankara, Ankara, Turkey; Karmanos Cancer Institute, Detroit Medical Center and Wayne State University, Detroit, MI 91 Hypoxia Response Pathway Markers in Clear Cell (Conventional) Renal Cell Carcinoma: A Tissue Microarray Based Immunohistochemical Study (579) HA Al-Ahmadie, SK Tickoo, D Alden, S Olgac, SW Fine, P Russo, RJ Motzer, VE Reuter - Memorial Sloan-Kettering Cancer Center, New York, NY 92 Clusterin Expression Differentiates Wild Type-VHL From VHL-Defective Sporadic Clear Cell Renal Cell Carcinomas (576) P Abreu-e-Lima, PM Sadow, E Nakamura, WG Kaelin, V Nosé - Brigham and Women's Hospital, Howard Hughes Medical Institute; Dana-Farber Cancer Institute, Boston, MA 93 Fat Poor Angiomyolipoma: Pathologic Definition With Radiologic And Clinical Correlation (730) TC Rubinas, T Antic, KT Perry, MM Picken - Loyola University Medical Center, Maywood, IL 94 Determination Of EGFR Status In Sporadic And Hereditary Renal Tumors. Correlation Between CISH And Immunohistochemistry (707) MA Palau, C Torres-Cabala, E Li Ning, WM Linehan, MJ Merino - NCI, Bethesda, MD; NCI, Bethesda, MD 95 Needle Tract Seeding of Perinephric Adipose Tissue Following Imaging-Guided Biopsy of Renal Tumors (758) P Tamboli, RF Tibbs, RF Sanchez-Ortiz, CG Wood, F Vakar-Lopez - MD Anderson Cancer Center, Houston, TX 96 Papillary Adenoma(s) in Renal Resection Specimens: Incidence and Relationship to Renal Neoplasia (759) P Tamboli, KL Burt, CG Wood, BA Czerniak - MD Anderson Cancer Center, Houston, TX 97 Renal Cell Carcinoma in Patients under 40 (736) MF Serrano, T Bullock, Y Yan, AS Kibel, PA Humphrey - Washington University School of Medicine, St. Louis, MO 98 Expression of PDGFR-alpha In Sarcomatoid Differentiation of Renal Cell Carcinoma (SRCC) (716) A Petit, A Gaspa, D Truan, I Nayach, PL Fernandez, C Mallofre - Hospital Clinic, Universitat de Barcelona, Barcelona, Spain 99 Histologic Characteristics and Clinical Behavior of Renal Cell Carcinoma in Young Adults: A Comparison to Older Age Patients (702) T Oak, JY Ro, LD Truong, AG Ayala, SS Shen - The Methodist Hospital, Houston, TX 100 Primary Leiomyomas And Leiomyosarcomas Of The Kidney: A Clinicopathologic Study Of Twenty Cases (717) DM Pierson, SM Jung, AM Oliveira, HH Dimashkieh, AG Nascimento, JC Cheville - Mayo Clinic, Rochester, MN 101 Expression of Galectin 3 in Renal Cell Carcinoma (RCC): A Tissue Microarray and Immunohistochemical Study (765) LD Truong, N Singal, R Amato, Q Zhai, S Shen - The Methodist Hospital, Baylor College of Medicine, Houston, TX; Weill Medical College of Cornell University, New York, NY 102 Analysis of PTEN Deletions in Clear Cell Renal Cell Carcinomas (CCRCC) Showing Intratumoral Grade Heterogeneity (733) A Saravanan, M Yoshimoto, JA Squire, AJ Evans - University Health Network, Ontraio Cancer Institute - Princess Margaret Hospital, Toronto, ON, Canada 103 Clinical, Radiographic, and Pathologic Characteristics of Cystic Nephroma (CN) and Mixed Epithelial Stromal Tumor of the Kidney (MEST) (669) B Lane, C Weight, C Magi-Galluzzi, H Levin, S Campbell, M Zhou - Cleveland Clinic, Cleveland, OH 104 Immunohistochemical Detection of Aquaporin 1 as an Aid in Identifying Renal Cell Carcinoma in the Setting of Metastatic Carcinomas of Unknown Primary (660) PL Kandalaft, TS Barry, SJ Kussick, LC Goldstein, C Bacchi, P Bitterman, AM Gown - PhenoPath Laboratories, PLLC and IMPRIS, Seattle, WA; Consultoria em Patologia, Botucatu, Sao Paulo, Brazil; Rush-Presbyterian-St Luke's Medical Center, Chicago, IL 105 Comparison of Melanocytic Markers in Renal Angiomyolipomas (726) A Roma, C Magi-Galluzzi, M Zhou - Cleveland Clinic, Cleveland, OH 106 Chromophobe Renal Cell Carcinoma and Oncocytoma Show Distinctive Expression Profiles by DNA Microarray and by Reverse Transcription-PCR Analysis (724) SM Rohan, JJ Tu, J Kao, Y-T Chen - Weill Medical College of Cornell University, New York, NY 107 Potential Pitfalls In Immunohistochemical Staining Of Renal Oncocytoma (701) C Njiwaji, M Che, O Tulunay, O Basturk, W Sakr, D Grignon - Karmanos Cancer Institute, Detroit Medical Center and Wayne State University, Detroit, MI 108 Classification of Renal Neoplasms on Needle Biopsies Based on Histology and a Molecular Diagnostic Algorithm (725) SM Rohan, M Akhtar, J Kao, DA Barocas, P Gumpeni, DS Scherr, Y-T Chen - Weill Medical College of Cornell University, Weill Medical College of Cornell University, New York, NY 109 Expression Of Kidney-Specific Cadherin In Chromophobe Renal Cell Carcinoma And Renal Oncocytoma (642) A Gupta, BP Adley, E Lin, C Luan, BT Teh, XJ Yang - Feinberg School of Medicine, Northwestern University, Chicago, IL 110 Endogenous Biotin Activity In Renal Oncocytoma (RO) And Chromophobe Renal Cell Carcinoma (ChRCC): A Significant Diagnostic Problem (767) O Tulunay, M Che, B Pruetz, C Njiwaji, W Sakr, D Grignon - Medical School of Ankara University, Ankara, Turkey; Karmanos Cancer Institute, Detroit Medical Center and Wayne State University, Detroit, MI 111 Renal Chromophobe Carcinomas With Focal Oncocytic-Like Morphology: Cytogenetic Analysis Of 5 Cases (636) A Goodwin, W Trotman, M Evans, J Richmond, K Cooper - University of Vermont; Fletcher Allen Health Care, Burlington, VT 112 Immunohistochemical Profile Of Renal Epithelial Neoplasms: An Institutional Experience With 92 Consecutive Cases (590) JP Balani, JF Catroppo, T McHale, S Bastacky, F Monzon, A Parwani, R Hrebinko, M Franks, R Dhir - University of Pittsburgh Medical Center, Pittsburgh, PA 113 Expression Of Kidney-Specific Cadherin (Ksp-Cad) In Rare And Unusual Renal Epithelial Neoplasms (REN). Diagnostic And Histogenetic Implications (666) A Kuehn, C Cohen, A Radhakrishan, B Shehata, M Datta, A Young, G Paner, MB Amin, JR Srigley - Emory University Hospital, Atlanta, GA; Credit Valley Hospital, Mississauga, ON, Canada 114 Fluorescence In-Situ Hybridization (FISH) Profile Of Renal Epithelial Neoplasms (REN): An Institutional Experience With 92 Consecutive Cases (591) JP Balani, JF Catroppo, T McHale, S Bastacky, F Monzon, A Parwani, R Hrebinko, M Franks, R Dhir - University of Pittsburgh Medical Center, Pittsburgh, PA 115 Hybrid Renal Cell Carcinoma with Clear Cell and Papillary Cytomorphological Features (665) DM Kohler, KT Mai, HM Yazdi - Ottawa Hospital, Civic Campus, Ottawa, ON, Canada 116 Loss of Expression of the Tumor Suppressor 14-3-3 Sigma Protein in Chromophobe Renal Cell Carcinoma Is Associates with Promoter Hypermethylation (785) M Zhou, L Wang, L Sercia, B Yang - The Cleveland Clinic, Cleveland, OH 117 The Genetic Alterations In Papillary Renal Cell Carcinoma (PRCC) Evaluated By DASL (cDNA-Mediated Annealing, Selection, Extension And Ligation) Assay System (769) O Tulunay, D Grignon, M Che, J Cortese, W Sakr, R Everson - Medical School of Ankara University, Ankara, Turkey; Karmanos Cancer Institute, Detroit Medical Center and Wayne State University, Detroit, MI